Registry of CLH intentions until outcome

Registry of CLH intentions until outcome

Registry of CLH intentions until outcome

The registry of classification and labelling (CLH) intentions until outcome lists the intentions and proposals received by ECHA for a new or revised harmonised classification and labelling of a substance. The proposals are submitted by Member State competent authorities, manufacturers, importers or downstream users.  

Interested parties can follow the progress of a proposal through the CLH process, from the notification of the intention to the adoption of the opinion of the Committee for Risk Assessment (RAC). The advance notice enables interested parties to plan and prepare for commenting later on.

Anyone with relevant information on the identity or hazard properties of a substance is encouraged to provide this information to the dossier submitter during the early stages of the process, or at the latest during the consultation.

Where an opinion has been adopted by RAC, the status is indicated as ‘Opinion Adopted’.

Note: The classification tables for those substances that have been reviewed are listed in the ‘Corrigenda to the RAC opinions’ document.

3,4-dimethyl-1H-pyrazole

EC / List no: 429-130-1 CAS no: 2820-37-3
CLP Annex VI Index number
613-248-00-5
Further substance information
Status
Opinion Development
Date of intention
24-Jan-2023
Expected date of submission
28-Feb-2023
Submitted for accordance check
24-Feb-2023
Final submission date
26-Jun-2023
Withdrawal date
Legal deadline for opinion adoption
25-Dec-2024
Submitter
Belgium
Submitter's email
Reach@health.fgov.be
Harmonised classification at the time of the proposal
Acute Tox. 4*, H302
Eye Dam. 1, H318
Aquatic Chronic 3, H412
Specific concentration limits at the time of the proposal
Proposed harmonised classification by the dossier submitter
Acute Tox. 4, H302
Acute Tox. 4, H312
Acute Tox. 4, H332
Eye Dam. 1, H318
Carc. 2, H351
Repr. 2, H361f
STOT RE 2, H373
Aquatic Chronic 3, H412
Proposed specific concentration limits by the dossier submitter
ATE (oral): 500 mg/kg bw
ATE (dermal): 1100 mg/kg bw
ATE (inhalation): 2.1 mg/l
H373 (nasal cavity)
Regulatory programme
Chemical registered under REACH
Remarks
Start of consultation
14-Aug-2023
Deadline for commenting
13-Oct-2023
Hazard classes open for commenting
Carcinogenicity
Reproductive toxicity
Acute Toxicity - inhalation
Acute Toxicity - dermal
Acute Toxicity - oral
Specific target organ toxicity — repeated exposure


CLH report
Annexes to the CLH report
Date of opinion
RAC Opinion
Background document
RCOM (Comments received)
Attachments received during consultation (excluding journal articles)
Minority opinion(s)
Other annexes
ATP number and date
Link to ATP
Latest update
31-Oct-2023
First published
20-Feb-2023